Transnational Corporation of Nigeria Plc (NGX:TRANSCORP)

Intra-Cellular Therapies Revenue

Transnational Corporation of Nigeria had revenue of 135.97B NGN in the quarter ending June 30, 2025, with 56.51% growth. This brings the company's revenue in the last twelve months to 512.17B, up 76.43% year-over-year. In the year 2024, Transnational Corporation of Nigeria had annual revenue of 407.92B with 107.07% growth.

• Revenue (ttm): 512.17B
• Revenue Growth: +76.43%
• P/S Ratio: 0.99
• Revenue / Employee: 291.83M
• Employees: 1,755
• Market Cap: 508.10B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	407.92B	210.93B	107.07%
Dec 31, 2023	196.99B	63.27B	47.32%
Dec 31, 2022	133.72B	22.50B	20.23%
Dec 31, 2021	111.22B	35.95B	47.76%
Dec 31, 2020	75.27B	-1.07B	-1.41%